The course of yersiniosis in infants: a review of the literature and clinical case
https://doi.org/10.22627/2072-8107-2026-25-2-29-35
Abstract
Due to the polymorphism of clinical manifestations, yersiniosis is a diagnostically complex infectious disease. The course of the disease in infants occupies a special place, as the limited amount of literature data and, as a result, insufficient vigilance on the part of specialists lead to a delay in diagnosis.
The aim of this study is to summarise current knowledge on the epidemiology, pathogenesis, clinical features, approaches to diagnosis and treatment of yersiniosis in infants, as well as to present our own clinical observations.
Materials and methods: We analysed the medical records of a nine-month-old child who was hospitalised in a paediatric multidisciplinary hospital with an intestinal form of yersiniosis, which manifested itself with pronounced gastrointestinal and intoxication symptoms, as well as the presence of exanthema, but without involvement of the joints, hepatobiliary system, or mesenteric lymph nodes. Current domestic and foreign scientific medical literature on yersiniosis infection in children was studied using search engines and databases such as eLibrary, PubMed, ResearchGate, Google Scholar, and Scopus.
Conclusion. In infants with acute intestinal infection accompanied by exanthema, yersiniosis should be included in the differential diagnosis, which in this age group usually manifests itself as a combination of intoxication and gastrointestinal syndromes with prolonged vomiting and diarrhoea, often mixed with blood, and characteristic punctate, maculopapular or haemorrhagic rash.
About the Authors
D. M. MuscherovaRussian Federation
Moscow
E. A. Sarkisyan
Russian Federation
Moscow
D. I. Fadyukhina
Russian Federation
Moscow
A. S. Ilyinskaya
Russian Federation
Moscow
O. I. Zhdanova
Russian Federation
Moscow
A. I. Vavilova
Russian Federation
Moscow
A. A. Kozlova
Russian Federation
Moscow
V. G. Shatalov
Russian Federation
Moscow
P. V. Shumilov
Russian Federation
Moscow
References
1. Bednarskaya EV, Dmitrenko NB, Berkovich NA, Proskurnin RV. Foci of yersiniosis in the Crimean Peninsula. Journal of Microbiology, Epidemiology and Immunobiology. 2025;102(1):102—111. doi: 10.36233/0372-9311-540 (In Russ).
2. Riahi SM, Ahmadi E, Zeinali T. Global Prevalence of Yersinia enterocolitica in Cases of Gastroenteritis: A Systematic Review and Meta-Analysis. Int J Microbiol. 2021 Sep 2;2021:1499869. doi: 10.1155/2021/1499869
3. Aletaha M, Heidarzadeh S, Rahimi Foroushani A, Soltan Dallal MM. Isolation and genetic profiling of Yersinia enterocolitica strains from diarrheal samples of Iranian children under 5: PCR ribotyping insights. Microb Pathog. 2025 Oct;207:107901. doi: 10.1016/j.micpath.2025.107901
4. European Food Safety Authority (EFSA); European Centre for Disease Prevention and Control (ECDC). The European Union One Health 2022 Zoonoses Report. EFSA J. 2023 Dec 12;21(12):e8442. doi: 10.2903/j.efsa.2023.8442
5. Saraiva S, García-Díez J, de Sousa T, Calouro R, Fernandes D, Mourão AV, et al. Zoonotic Yersinia enterocolitica in Swine: One Health Implications for Food Safety and Public Health. Vet Sci. 2025 Aug 23;12(9):795. doi: 10.3390/vetsci12090795
6. Bottone EJ. Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev. 1997 Apr;10(2):257—276. doi: 10.1128/CMR.10.2.257
7. Infectious diseases: national guidelines. Yushchuk ND, Vengerov YuYa, editors. 3rd ed. Moscow: GEOTAR-Media; 2021. (National guidelines series). doi: 10.33029/9704-6122-8-INB-2021-1-1104. ISBN 978-5-9704-6122-8 (In Russ).
8. Le Guern AS, Savin C, Chereau F, Tessier S, Guglielmini J, Brémont S, et al. A novel cgMLST for genomic surveillance of Yersinia enterocolitica infections in France allowed the detection and investigation of outbreaks in 2017— 2021. Microbiol Spectr. 2024 Jun 4;12(6):e0050424. doi: 10.1128/spectrum.00504-24
9. Grygiel-Górniak B. Current Challenges in Yersinia Diagnosis and Treatment. Microorganisms. 2025 May 15;13(5):1133. doi: 10.3390/microorganisms13051133
10. Suldina EV, Mastilenko AV, Feoktistova NA, Mayorov PS. Assessment of the potential of using bacteriophage Y-8 ULGAU as part of a combined biological disinfectant. Bulletin of Ulyanovsk State Agricultural Academy. 2023;4(64):103—108. doi: 10.18286/1816-4501-2023-4-103-108 (In Russ).
11. American Academy of Pediatrics. Red Book: 2021 Report of the Committee on Infectious Diseases. Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, editors. Itasca, IL: American Academy of Pediatrics; 2021. p. 852—854. ISBN 978-1-61002-521-8
12. Arsić M, Vićić I, Petrović M, Dmitrić M, Karabasil N. Yersinia enterocolitica and Control Measures for Reducing Risks in the Pork Production Chain. Meat Technol. 2023;64:237—241. doi: 10.18485/meattech.2023.64.2.43
13. Escoffier P, Gendrin V, Poloni S, Clerc J, Ducournau A, Klopfenstein T, et al. Disseminated Yersinia enterocolitica infection associated to Sweet's syndrome. BMC Infect Dis. 2024 Sep 27;24(1):1036. doi: 10.1186/s12879-024-09968-9
14. Fredriksson-Ahomaa M, Grönthal T, Heljanko V, Johansson V, Rantala M, Heikinheimo A, et al. Enteropathogenic Yersinia with Public Health Relevance Found in Dogs and Cats in Finland. Pathogens. 2024 Jan 5;13(1):54. doi: 10.3390/pathogens13010054
15. Yue Y, Zheng J, Sheng M, Liu X, Hao Q, Zhang S, et al. Public health implications of Yersinia enterocolitica investigation: an ecological modeling and molecular epidemiology study. Infect Dis Poverty. 2023 Apr 21;12(1):41. doi: 10.1186/s40249-023-01063-6
16. Dorozhenkova TE, Gorbich OA. Epidemiological characteristics and basics of prevention of intestinal yersiniosis and pseudotuberculosis: teaching aid. Minsk: BSMU; 2022. 47 p. ISBN 978-985-21-1176-8 (In Russ).
17. Haidar-Alame S, Raudszus A, Sahai S, Abdel-Haq N. A Child With Kawasaki Disease and Yersinia enterocolitica Infection: A Closer Look at Pathogenesis. Glob Pediatr Health. 2015 Jun 16;2:2333794X15591563. doi: 10.1177/2333794X15591563
18. Seabaugh JA, Anderson DM. Pathogenicity and virulence of Yersinia. Virulence. 2024 Dec;15(1):2316439. doi: 10.1080/21505594.2024.2316439
19. Stevens MJA, Horlbog JA, Diethelm A, Stephan R, Nüesch-Inderbinen M. Characteristics and comparative genome analysis of Yersinia enterocolitica and related species associated with human infections in Switzerland 2019— 2023. Infect Genet Evol. 2024 Sep;123:105652. doi: 10.1016/j.meegid.2024.105652
20. Koskinen J, Ortiz-Martínez P, Keto-Timonen R, Joutsen S, Fredriksson-Ahomaa M, Korkeala H. Prudent Antimicrobial Use Is Essential to Prevent the Emergence of Antimicrobial Resistance in Yersinia enterocolitica 4/O:3 Strains in Pigs. Front Microbiol. 2022 Mar 10;13:841841. doi: 10.3389/fmicb.2022.841841
21. Quion NB, Torga AP. Yersinia Enterocolitica. Pediatr Rev. 2021 Dec;42(12):712—713. doi: 10.1542/pir.2020-003830
22. Ospanbekova NK, Dmitrovsky AM, Ospanbekova AK. Spectrum of clinical manifestations of diseases caused by representatives of the genus Yersinia (yersiniosis) in adult patients hospitalized in an infectious diseases hospital. Sciences of Europe. 2021;1(83):6—9. doi: 10.24412/3162-2364-2021-83-1-6-9 (In Russ).
23. Revés J, Frias-Gomes C, Ramos LR, Glória L. Positive Yersinia Serology and Colonic Cobblestone Pattern: A Diversion or Main Culprit? GE Port J Gastroenterol. 2024 Sep 30;32(2):143—150. doi: 10.1159/000541220
24. Feakins R, Torres J, Borralho-Nunes P, Burisch J, Cúrdia Gonçalves T, De Ridder L, et al. ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease. J Crohns Colitis. 2022 Mar 14;16(3):343—368. doi: 10.1093/ecco-jcc/jjab141
25. Infectious diseases in children: textbook. Uchaikin VF, Shamsheva OV, editors. 3rd ed. Moscow: GEOTAR-Media; 2022. 920 p. doi: 10.33029/ 9704-5654-5-IBD-2021-1-920. ISBN 978-5-9704-7032-9 (In Russ).
26. Hassan SM, Doolittle BR. A case of Yersinia enterocolitica mimicking Kawasaki disease. Rheumatology (Oxford). 2009 Jul;48(7):857—858. doi: 10.1093/rheumatology/kep076
27. Ohnishi T, Sato S, Kinoshita K, Takei H, Furuichi M, Uejima Y, et al. A Case of Intravenous Immunoglobulin-Resistant Kawasaki Disease With Yersinia enterocolitica Enterocolitis Successfully Treated With Cefotaxime Following Infliximab and Cyclosporine. J Pediatric Infect Dis Soc. 2021 Mar 26;10(2):225—226. doi: 10.1093/jpids/piaa034
Review
For citations:
Muscherova D.M., Sarkisyan E.A., Fadyukhina D.I., Ilyinskaya A.S., Zhdanova O.I., Vavilova A.I., Kozlova A.A., Shatalov V.G., Shumilov P.V. The course of yersiniosis in infants: a review of the literature and clinical case. CHILDREN INFECTIONS. 2026;25(2):29-35. (In Russ.) https://doi.org/10.22627/2072-8107-2026-25-2-29-35
JATS XML




































